<h4>Background</h4>Interleukin-6 receptor (IL-6R) inhibition by tocilizumab improves myocardial salvage index (MSI) in ST-elevation myocardial infarction (STEMI). Here, IL6R is linked to ST Elevation Myocardial Infarction.